E/M Coding Alert - 2004 Issue 32
Physicians: Medicare Drugs Slashed Up To 90 Percent Next Year
Subscribe or sign in to view the full article.
Article Overview
This article covers proposed Medicare reimbursement changes affecting physician practices that provide administered drugs under Part B, along with the separate administration fees tied to those services. It discusses CMS’s 2005 rule, the direction of payment changes, the budgetary impact estimates, and the public-comment timeline. The piece is relevant to physicians, practice managers, and medical coders who track Medicare payment policy and service-level billing guidance.
Why This Topic Matters
Payment policy changes can affect physician office revenue, patient cost-sharing, and how practices monitor Medicare drug-related billing activity. Understanding the scope of the proposed rule and the administration-fee changes helps stakeholders prepare for annual updates and compliance review.
What You Will Learn
- What Medicare payment policy changes are being discussed for physician-administered drugs
- How CMS described the relationship between drug payments and administration fees
- What broad financial and timing impacts were projected for the 2005 rule
- Which kinds of physician services were used as payment examples in the article
- What administrative and public-comment milestones were noted for the proposed rule
Who Should Read This
- Physicians
- Practice managers
- Medical coders
- Billing staff
- Healthcare compliance professionals
- Revenue cycle staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com